INTRODUCTION
Pulmonary hypertension (PH) is a rare condition with a high incidence of maternal and perinatal mortality (30-56% and 10-13%, respectively). Pulmonary hypertension is a contraindication to pregnancy because of high risk of maternal death, therefore the World Health Organisation (WHO) advises to discuss a termination in the event of pregnancy with women suffering from PH.
CASE REPORT
A 34-year-old primigravida was admitted due to new-onset dyspnoea, fatigue and central cyanosis. Medical history was non-contributory: she denied prior cardiopulmonary diseases and any signs or symptoms suggestive of cardiac abnormalities. However, since the beginning of the 2 nd trimester of pregnancy she has complained of a non-productive cough, intensified by exertion.
The transthoracic echocardiography revealed a mitral valve thickening with limited cusps mobility. An estimated mitral valve area was 1.1 cm 2 , with peak and mean diastolic gradients across the valve 29 and 17 mm Hg. Left ventricular ejection fraction was 60%. The tricuspid regurgitation pressure gradient (TRPG) reached 80 mm Hg. Distended vena cava inferior was detected and right ventricular systolic pressure (RVSP) reached 100 mm Hg. The patient was diagnosed with severe PH secondary to severe mitral stenosis. Therapy with 40 mg furosemide was administered once daily. Percutaneous mitral valvuloplasty was considered, however, due to relatively stable condition it was not performed during pregnancy. The patient was in a stable general condition but presented a high risk of a pulmonary oedema and tachyarrhythmias with possible deterioration of patients' condition. Figure 3 . Echocardiography on the 6 th day after delivery. Slightly lower peak (maxPG) and mean (meanPG) gradients across the mitral valve
